Key Takeaways
- • Two Sigma Investments is closing its $120 million Eclipse fund, a legacy vehicle launched in the early 2000s, with mandatory redemption of all investor interests effective December 31, 2025.
- • Eclipse represents a small fraction of Two Sigma's $70 billion-plus in assets under management and has been gradually returning capital to investors without replacing redemptions, making it an underperforming legacy vehicle.
- • The fund closure is part of a broader organizational simplification effort at Two Sigma, which has undergone significant structural changes including leadership transitions and a roughly 10% workforce reduction.
- • Investors in Eclipse will have the option to reinvest redeemed capital into Two Sigma's Spectrum funds, while the underlying macro and equities trading strategies will continue across other firm vehicles.
- • The closure comes amid ongoing internal management challenges at Two Sigma, including the resolution of a multiyear founder dispute and recent legal issues involving a former quantitative researcher accused of model manipulation.
Summary
Two Sigma Investments announced the closure of its $120 million Eclipse fund, a legacy investment vehicle launched in the early 2000s that focused on macro and equities trading strategies. The firm has notified investors that all interests in the fund will be compulsorily redeemed, with the closure scheduled for December 31, 2025, according to Bloomberg reporting on an investor communication.
Eclipse has been a diminishing asset within Two Sigma's broader portfolio, representing only a small portion of the firm's $70 billion-plus in assets under management. The fund has been in a gradual capital return mode for several years, failing to attract new investor commitments and experiencing net outflows as existing investors have redeemed positions without replacement.
The decision to wind down Eclipse reflects Two Sigma's strategic effort to streamline its fund structure and eliminate legacy vehicles that no longer align with the firm's current investment priorities. Investors holding Eclipse shares will have the flexibility to reinvest their redeemed capital into Two Sigma's Spectrum funds, ensuring continuity of client relationships while consolidating the firm's product offerings. The underlying strategies employed by Eclipse will continue to operate within other Two Sigma investment vehicles.
The closure occurs during a period of significant organizational transformation at Two Sigma. The firm has been managing internal transitions following a prolonged dispute between co-founders John Overdeck and David Siegel, who both stepped back from daily operations in 2024. Overdeck has since returned to the management committee. Two Sigma recently appointed new co-CEOs as part of its leadership restructuring and implemented a workforce reduction of approximately 10%.
The firm faces additional headwinds related to operational and compliance matters, including charges against a former quantitative researcher accused of manipulating performance models to artificially inflate fund returns. These cumulative challenges—combined with the closure of an underperforming legacy fund—underscore Two Sigma's efforts to reset its organizational structure and investor confidence following a turbulent period.
Eclipse has been a diminishing asset within Two Sigma's broader portfolio, representing only a small portion of the firm's $70 billion-plus in assets under management. The fund has been in a gradual capital return mode for several years, failing to attract new investor commitments and experiencing net outflows as existing investors have redeemed positions without replacement.
The decision to wind down Eclipse reflects Two Sigma's strategic effort to streamline its fund structure and eliminate legacy vehicles that no longer align with the firm's current investment priorities. Investors holding Eclipse shares will have the flexibility to reinvest their redeemed capital into Two Sigma's Spectrum funds, ensuring continuity of client relationships while consolidating the firm's product offerings. The underlying strategies employed by Eclipse will continue to operate within other Two Sigma investment vehicles.
The closure occurs during a period of significant organizational transformation at Two Sigma. The firm has been managing internal transitions following a prolonged dispute between co-founders John Overdeck and David Siegel, who both stepped back from daily operations in 2024. Overdeck has since returned to the management committee. Two Sigma recently appointed new co-CEOs as part of its leadership restructuring and implemented a workforce reduction of approximately 10%.
The firm faces additional headwinds related to operational and compliance matters, including charges against a former quantitative researcher accused of manipulating performance models to artificially inflate fund returns. These cumulative challenges—combined with the closure of an underperforming legacy fund—underscore Two Sigma's efforts to reset its organizational structure and investor confidence following a turbulent period.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.